Abstract
The authors describe a 3-year-old female, diagnosed with GLUT1 deficiency Syndrome, with a previously unreported mutation in exon 7 of the SLC2A1 gene: c.968_972 + 3del P. (Val323Alafs*53), characterized by a classic phenotypic of acquired microcephaly, developmental delay, ataxia, spasticity, and epilepsy. Ketogenic diet was started at the age of 30 months with epilepsy improvement. She presented paroxysmal ocular movements in the first 12 months of life, recently defined as “aberrant gaze saccades”, that are present in the early phase of visual system development, being one of the first disease signs, but easily disregarded. Recognizing these particular ocular movements would allow an early diagnosis, followed by ketogenic diet implementation, improving significantly the prognosis and the neurological development of those children.
References
Akman CI, Yu J, Alter A, Engelstad K, De Vivo DC (2016) Diagnosing glucose transporter 1 deficiency at initial presentation facilitates early treatment. J Pediatr 171:220–226
Alter AS, Engelstad K, Hinton VJ et al (2015) Long-term clinical course of Glut1 deficiency syndrome. J Child Neurol 30:160–169
Coman DJ, Sinclair KG, Burke CJ, Appleton DB, Pelekanos JT, O'Neil CM et al (2006) Seizures, ataxia, developmental delay and the general paediatrician: glucose transporter 1 deficiency syndrome. J Paediatr Child Health 42(5):263–267
De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI (1991) Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 325:703–709
De Vivo DC, Leary L, Wang D (2002) Glucose transporter 1 deficiency syndrome and other glycolytic defects. J Child Neurol 17 Suppl 3:3S15–3S23; discussion 13S24–25
Dressler A, Trimmel-Schwahofer P, Reithofer E, Grddotoppel G, Muhlebner A, Samueli S et al (2015) The ketogenic diet in infants – advantages of early use. Epilepsy Res 116:53–58
Friedman JR, Thiele EA, Wang D et al (2006) Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic diet. Mov Disord 21:241–245
Leen WG, Klepper J, Verbeek MM et al (2010) Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 133:655–670
Pearson TS, Pons R, Engelstad K, Kane SA, Goldberg ME, De Vivo DC (2017) Paroxysmal eye–head movements in Glut1 deficiency syndrome. Neurology 88(17):1666–1673
Pons R, Collins A, Rotstein M, Engelstad K, De Vivo DC (2010) The spectrum of movement disorders in Glut-1 deficiency. Mov Disord 25:275–281
Seidner G, Alvarez MG, Yeh JI et al (1998) GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet 18:188–191
Van der Louw E, Van den Hurk D, Neal E, Leiendecker B, Fitzsimmon G, Dority L et al (2016) Ketogenic diet guidelines for infants with refractory Epilepsy. Eur J Paediatr Neurol 20(6):789–809
Wang D, Pascual JM, Yang H et al (2005) Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol 57:111–118
Wong HY, Chu TS, Lai JC, Fung KP, Fok TF, Fujii T et al (2005) Sodium valproate inhibits glucose transport and exacerbates Glut1-deficiency in vitro. J Cell Biochem 96(4):775–785
Yang H, Wang D, Engelstad K et al (2011) Glut1 deficiency syndrome and erythrocyte glucose uptake assay. Ann Neurol 70:996–1005
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflicts of interest.
Informed consent
Written informed consent was obtained from the parents of the patient for publication of this Case report and any accompanying images/video.
Rights and permissions
About this article
Cite this article
Reis, S., Matias, J., Machado, R. et al. Paroxysmal ocular movements – an early sign in Glut1 deficiency Syndrome. Metab Brain Dis 33, 1381–1383 (2018). https://doi.org/10.1007/s11011-018-0225-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-018-0225-3